Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Dr. Laurent FischerIndependent Director | 3,98k | 0,00 | Derivative Exercise and Retained Stock | - | 10,73k | 58,92% |
| 2026-05-29 | Dr. Lon CardonIndependent Director | 3,98k | 0,00 | Derivative Exercise and Retained Stock | - | 9,68k | 69,74% |
| 2026-05-29 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -3,98k | 397,70k | Derivative Exercise and Sale | 100,00 | - | - |
| 2026-05-29 | Mr. Timothy P. WalbertIndependent Director | 3,98k | 0,00 | Derivative Exercise and Retained Stock | - | 9,68k | 69,74% |
| 2026-05-15 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2,00k | 171,92k | Derivative Exercise and Sale | 23,51 - 109,47 | 0,00 | - |
| 2026-04-15 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2,00k | 146,78k | Derivative Exercise and Sale | 23,51 - 96,90 | 0,00 | - |
| 2026-03-15 | Mr. Eric H. BjerkholtCFO | 6,05k | 0,00 | Derivative Exercise and Retained Stock | - | 49,79k | 13,82% |
| 2026-03-15 | Mr. Eric H. BjerkholtCFO | -7,29k | 670,24k | Derivative Exercise and Sale | 91,98 | 49,79k | - |
| 2026-03-16 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2,00k | 134,50k | Derivative Exercise and Sale | 23,51 - 90,76 | - | - |
| 2026-03-15 | Mr. Peter RadovichCOO & President | 13,71k | 0,00 | Derivative Exercise and Retained Stock | - | 40,27k | 51,59% |
| 2026-03-15 | Mr. Peter RadovichCOO & President | -16,52k | 1,52M | Derivative Exercise and Sale | 91,98 | 40,27k | - |
| 2026-03-15 | Ms. Jolanda HoweSenior VP & Global Controller | 3,93k | 0,00 | Derivative Exercise and Retained Stock | - | 8,43k | 87,19% |
| 2026-03-15 | Ms. Jolanda HoweSenior VP & Global Controller | -4,73k | 435,24k | Derivative Exercise and Sale | 91,98 | 8,43k | - |
| 2026-03-15 | Dr. Joanne M. J. QuanChief Medical Officer | 6,05k | 0,00 | Derivative Exercise and Retained Stock | - | 18,86k | 47,18% |
| 2026-03-15 | Dr. Joanne M. J. QuanChief Medical Officer | -7,29k | 670,24k | Derivative Exercise and Sale | 91,98 | 18,86k | - |
| 2026-03-15 | Mr. Christopher PeetzCEO & Director | 34,02k | 0,00 | Derivative Exercise and Retained Stock | - | 381,81k | 9,78% |
| 2026-03-15 | Mr. Christopher PeetzCEO & Director | -40,99k | 3,77M | Derivative Exercise and Sale | 91,98 | 381,81k | - |
| 2026-03-06 | Mr. Peter RadovichCOO & President | 5,91k | 93,82k | Derivative Exercise and Retained Stock | 15,87 | 26,57k | 28,62% |
| 2026-02-13 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2,00k | 157,16k | Derivative Exercise and Sale | 23,51 - 102,09 | 0,00 | - |
| 2026-01-31 | Ms. Jolanda HoweSenior VP & Global Controller | 803,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,50k | 21,70% |
| 2026-01-31 | Ms. Jolanda HoweSenior VP & Global Controller | -968,00 | 100,00k | Derivative Exercise and Sale | 103,30 | 4,50k | - |
| 2026-02-02 | Mr. Christopher PeetzCEO & Director | -9,11k | 940,89k | Verkauf | 103,30 | 347,79k | -2,55% |
| 2026-02-02 | Mr. Peter RadovichCOO & President | -2,63k | 271,79k | Verkauf | 103,30 | 20,66k | -11,30% |
| 2026-01-23 | Mr. Christopher PeetzCEO & Director | 5,67k | 0,00 | Derivative Exercise and Retained Stock | - | 340,24k | 1,69% |
| 2026-01-23 | Mr. Christopher PeetzCEO & Director | -6,83k | 657,09k | Derivative Exercise and Sale | 96,19 | 340,24k | - |
| 2026-01-23 | Mr. Peter RadovichCOO & President | 2,61k | 0,00 | Derivative Exercise and Retained Stock | - | 18,47k | 16,43% |
| 2026-01-23 | Mr. Peter RadovichCOO & President | -3,14k | 302,33k | Derivative Exercise and Sale | 96,19 | 18,47k | - |
| 2026-01-23 | Mr. Eric H. BjerkholtCFO | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 43,74k | 3,83% |
| 2026-01-23 | Mr. Eric H. BjerkholtCFO | -1,05k | 101,29k | Derivative Exercise and Sale | 96,19 | 43,74k | - |
| 2026-01-23 | Ms. Jolanda HoweSenior VP & Global Controller | 658,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,70k | 21,63% |
| 2026-01-23 | Ms. Jolanda HoweSenior VP & Global Controller | -842,00 | 80,99k | Derivative Exercise and Sale | 96,19 | 3,70k | - |
| 2026-01-23 | Frazier Life Sciences Management, LPUnternehmen | 131,43k | 9,00M | Kauf | 68,48 | 7,09M | 1,89% |
| 2026-01-23 | Frazier Life Sciences Management, LPUnternehmen | 593,86k | 21,03M | Kauf | 68,48 | 1,14M | 108,97% |
| 2026-01-21 | Dr. Joanne M. J. QuanChief Medical Officer | 1,51k | 0,00 | Derivative Exercise and Retained Stock | - | 12,82k | 13,37% |
| 2026-01-21 | Dr. Joanne M. J. QuanChief Medical Officer | -1,82k | 170,04k | Derivative Exercise and Sale | 93,33 | 12,82k | - |
| 2026-01-21 | Ms. Jolanda HoweSenior VP & Global Controller | 616,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,04k | 25,39% |
| 2026-01-21 | Ms. Jolanda HoweSenior VP & Global Controller | -926,00 | 86,42k | Derivative Exercise and Sale | 93,33 | 3,04k | - |
| 2026-01-21 | Mr. Peter RadovichCOO & President | -2,38k | 222,30k | Derivative Exercise and Sale | 93,33 | 11,68k | - |
| 2026-01-21 | Mr. Peter RadovichCOO & President | 1,79k | 0,00 | Derivative Exercise and Retained Stock | - | 11,68k | 18,04% |
| 2026-01-21 | Mr. Eric H. BjerkholtCFO | 1,91k | 0,00 | Derivative Exercise and Retained Stock | - | 42,13k | 4,76% |
| 2026-01-21 | Mr. Eric H. BjerkholtCFO | -1,42k | 132,62k | Derivative Exercise and Sale | 93,33 | 42,13k | - |
| 2026-01-21 | Mr. Christopher PeetzCEO & Director | 5,70k | 0,00 | Derivative Exercise and Retained Stock | - | 334,57k | 1,73% |
| 2026-01-21 | Mr. Christopher PeetzCEO & Director | -7,10k | 662,42k | Derivative Exercise and Sale | 93,33 | 334,57k | - |
| 2026-01-16 | Dr. Joanne M. J. QuanChief Medical Officer | 5,59k | 0,00 | Derivative Exercise and Retained Stock | - | 11,31k | 97,78% |
| 2026-01-16 | Dr. Joanne M. J. QuanChief Medical Officer | -6,91k | 623,85k | Derivative Exercise and Sale | 90,27 | 11,31k | - |
| 2026-01-15 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2,00k | 134,96k | Derivative Exercise and Sale | 23,51 - 90,99 | 0,00 | - |
| 2025-12-31 | Mr. Christopher PeetzCEO & Director | -21,07k | 0,00 | Other Disposition | - | 331,16k | -5,98% |
| 2025-12-22 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -5,00k | 282,45k | Derivative Exercise and Sale | 23,51 - 80,00 | 0,00 | - |
| 2025-12-19 | Mr. Michael G. GreyIndependent Non-Executive Chairman of the Board | -50,00k | 3,75M | Derivative Exercise and Sale | 2,94 - 78,00 | 280,16k | - |
| 2025-12-18 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2,00k | 92,44k | Derivative Exercise and Sale | 23,51 - 70,00 | 0,00 | - |
| 2025-12-01 | Mr. Michael G. GreyIndependent Non-Executive Chairman of the Board | -50,00k | 3,55M | Derivative Exercise and Sale | 2,94 - 74,00 | 280,16k | - |
| 2025-11-21 | Mr. Michael G. GreyIndependent Non-Executive Chairman of the Board | -50,00k | 3,35M | Derivative Exercise and Sale | 2,94 - 70,00 | 280,16k | - |
| 2025-11-18 | Mr. Christopher PeetzCEO & Director | 19,13k | 368,12k | Derivative Exercise and Retained Stock | 19,24 | 349,31k | 5,79% |
| 2025-11-01 | Frazier Life Sciences Public Overage Fund, L.P.Unternehmen | -940,57k | 0,00 | Verkauf | - | 0,00 | -100,00% |
| 2025-11-01 | Frazier Life Sciences Management, LPUnternehmen | 940,57k | 0,00 | Kauf | - | 2,51M | 59,74% |
| 2025-09-11 | Mr. Eric H. BjerkholtCFO | 8,76k | 0,00 | Derivative Exercise and Retained Stock | - | 39,95k | 28,07% |
| 2025-09-11 | Mr. Eric H. BjerkholtCFO | -9,58k | 728,02k | Derivative Exercise and Sale | 76,01 | 39,95k | - |
| 2025-09-11 | Ms. Laura A. BregeIndependent Director | -17,00k | 1,01M | Derivative Exercise and Sale | 15,00 - 75,07 | 15,70k | - |
| 2025-09-08 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -17,00k | 399,67k | Derivative Exercise and Sale | - | 0,00 | - |
| 2025-08-12 | Mr. Eric H. BjerkholtCFO | 2,95k | 78,25k | Derivative Exercise and Retained Stock | 26,49 | 31,19k | 10,46% |
| 2025-08-11 | Mr. Eric H. BjerkholtCFO | -8,00k | 0,00 | Verkauf | - | 31,19k | -20,41% |
| 2025-08-11 | Mr. Christopher PeetzCEO & Director | -40,00k | 2,36M | Derivative Exercise and Sale | 2,94 - 62,00 | 324,29k | - |
| 2025-08-07 | Ms. Jolanda HoweSenior VP & Global Controller | -10,00k | 517,30k | Derivative Exercise and Sale | 6,27 - 58,00 | 2,43k | - |
| 2025-08-07 | Mr. Christopher PeetzCEO & Director | -40,00k | 2,09M | Derivative Exercise and Sale | 2,94 - 55,25 | 324,29k | - |
| 2025-07-01 | Ms. Jolanda HoweSenior VP & Global Controller | -1,04k | 50,62k | Derivative Exercise and Sale | 48,25 - 49,08 | 2,43k | - |
| 2025-06-11 | Mr. William Carl FaireyIndependent Director | -3,20k | 155,09k | Verkauf | 48,42 | 2,50k | -56,16% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
